Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Etravirine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    28 result(s) found for: Etravirine. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2012-002630-36 Sponsor Protocol Number: P1090 Start Date*: 2014-02-25
    Sponsor Name:The National Institute of Allergy and Infectious Diseases (NIAID) [...]
    1. The National Institute of Allergy and Infectious Diseases (NIAID)
    2. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Full Title: A PHASE I/II, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND ANTIVIRAL ACTIVITY OF ETRAVIRINE (ETR) IN ANTIRETROVIRAL (ARV) TREATMENT-EXPERIENCED HIV-1 INFECTED INFANT...
    Medical condition: HIV-1 infection
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004862 10068341 HIV-1 infection LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2009-014480-39 Sponsor Protocol Number: LLC-RAET-2009-1 Start Date*: 2010-02-18
    Sponsor Name:Luis Fernando López Cortés
    Full Title: Concentraciones plasmáticas e intracelulares de Raltegravir y Etravirina administrados una vez al día (800 mg y 400 mg, respectivamente) comparado con su dosificación estándard (400 mg y 200 mg/12 ...
    Medical condition: Pacientes con infección por el VIH en tratamiento con raltegravir o etravirina. HIV-Patients on treatment with raltegravir or etravirine
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-023532-16 Sponsor Protocol Number: TMC125IFD3002 Start Date*: 2012-01-26
    Sponsor Name:Janssen R&D Ireland
    Full Title: An open-label study to evaluate the safety, tolerability and pharmacokinetics of etravirine (ETR) in combination with other antiretrovirals (ARVs) in antiretroviral treatment-experienced HIV-1 infe...
    Medical condition: HIV-1 infection
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004862 10020192 HIV-1 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: RO (Completed)
    Trial results: View results
    EudraCT Number: 2007-000670-23 Sponsor Protocol Number: ANRS 139 Start Date*: 2007-03-21
    Sponsor Name:Agence nationale de recherches sur le sida et les hépatites virales. ANRS
    Full Title: Essai pilote évaluant un traitement antirétroviral associant le MK-0518, le darunavir/ritonavir (TMC114/r) et l’etravirine (TMC125) chez les patients infectés par le VIH-1, en échec virologique et ...
    Medical condition: Infection VIH
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020161 HIV infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2022-001591-33 Sponsor Protocol Number: DoRSwitch.21 Start Date*: 2022-10-06
    Sponsor Name:Fundació Clinic per a la Recerca Biomèdica
    Full Title: Open-label, single-arm, unicenter and Pilot Study of a Switch strategy from Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance
    Medical condition: Human Immunodeficiency Virus (HIV)
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-000828-24 Sponsor Protocol Number: ANRS163ETRAL Start Date*: 2015-05-31
    Sponsor Name:Inserm-ANRS
    Full Title: A non-comparative phase II trial evaluating the capacity of the dual combination raltegravir/etravirine to maintain virological success in HIV-1 infected patients of at least 45 years of age with a...
    Medical condition: HIV infection
    Disease: Version SOC Term Classification Code Term Level
    18.0 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-013126-16 Sponsor Protocol Number: TMC125-TiDP35-C239 Start Date*: 2009-11-09
    Sponsor Name:Tibotec Pharmaceuticals c/o Tibotec BVBA
    Full Title: Continued access to etravirine in treatment experienced HIV-1 infected children and adolescents.
    Medical condition: HIV-1 Infection
    Disease: Version SOC Term Classification Code Term Level
    12.0 10020192 HIV-1 LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA) FR (Ongoing) ES (Ongoing) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000674-20 Sponsor Protocol Number: SSAT 029 Start Date*: 2008-05-22
    Sponsor Name:St Stephen's Aids Trust
    Full Title: A phase III, double blind, multi centre, randomised placebo controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing Central Nervous System (CN...
    Medical condition: HIV
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-016455-21 Sponsor Protocol Number: ETRA-SWITCH Start Date*: 2009-12-03
    Sponsor Name:Fundació Lluita contra la SIDA
    Full Title: PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF SWITCHING PROTEASE INHIBITOR TO ETRAVIRINE IN HIV-1-INFECTED SUBJECTS WITH VIREMIA SUPPRESSION (ESTUDIO PILOTO PARA EVALUAR LA EFICACIA Y SEGURIDAD ...
    Medical condition: Infección por el VIH.
    Disease: Version SOC Term Classification Code Term Level
    9 10008919 Chronic HIV infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2010-022201-18 Sponsor Protocol Number: 26072010 Start Date*: 2011-03-28
    Sponsor Name:Daniel Podzamczer
    Full Title: EVALUACIÓN DE LOS NIVELES DE ETRAVIRINA EN LÍQUIDO CEFALORAQUÍDEO (LCR) EN SUJETOS INFECTADOS POR EL VIH
    Medical condition: antiviral inhibidor no nucleosídico de la transcriptasa inversa
    Disease: Version SOC Term Classification Code Term Level
    13 10068724 Tratamiento antiviral PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-002618-38 Sponsor Protocol Number: 721 Start Date*: 2020-06-25
    Sponsor Name:ASSOCIAZIONE "LA NOSTRA FAMIGLIA" - SEZIONE SCIENTIFICA I.R.C.C.S. "E.MEDEA"
    Full Title: Clinical trial - phase II - to test safety and efficay of Etravirine's treatment in Friedreich Ataxia's patients
    Medical condition: Friedreich's ataxia
    Disease: Version SOC Term Classification Code Term Level
    20.0 10010331 - Congenital, familial and genetic disorders 10017374 Friedreich's ataxia PT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-010887-41 Sponsor Protocol Number: TMC125-TiDP2-C238 Start Date*: 2009-06-22
    Sponsor Name:Tibotec Pharmaceuticals
    Full Title: A randomized, exploratory, open-label 48-week trial with a 2-week Pre-Treatment Phase to investigate the pharmacokinetics, safety, tolerability and antiviral activity of etravirine (ETR) in combina...
    Medical condition: HIV-1 infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020192 HIV-1 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-008655-42 Sponsor Protocol Number: TMC125VIR2038 Start Date*: 2009-03-31
    Sponsor Name:Janssen Cilag International
    Full Title: A Phase IIb, multi-centre, randomised, double-blind, active-controlled, trial comparing the neuropsychiatric adverse event profile of etravirine 400 mg q.d. versus efavirenz 600 mg q.d. in combinat...
    Medical condition: HIV-1 infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020192 HIV-1 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed) HU (Completed) AT (Completed) DE (Completed) GB (Completed) FR (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-011816-39 Sponsor Protocol Number: Start Date*: 2010-01-21
    Sponsor Name:Imperial College London
    Full Title: A randomised, open label, prospective study to assess two different therapeutic strategies following first treatment failure in HIV-1 infected subjects. ‘The First Failure Study’ : ‘FAST’
    Medical condition: HIV
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-005297-37 Sponsor Protocol Number: 3552 Start Date*: 2016-02-10
    Sponsor Name:King's College Hospital NHS Foundation Trust
    Full Title: Bone Evaluation in HIV-positive women over 40 who Switch from TDF + 3TC/FTC + NNRTI to Triumeq
    Medical condition: Human Immunodeficiency Virus
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004862 10020434 Human immunodeficiency virus infection causing other specified conditions LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-004392-19 Sponsor Protocol Number: A5271022 Start Date*: 2009-05-20
    Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017
    Full Title: A PHASE 2B MULTICENTER, RANDOMIZED, COMPARATIVE TRIAL OF UK-453,061 VERSUS ETRAVIRINE IN COMBINATION WITH DARUNAVIR/RITONAVIR AND A NUCLEOTIDE/NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR FOR THE TRE...
    Medical condition: HIV-1 Infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020161 HIV infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) GB (Completed) ES (Prematurely Ended) PT (Prematurely Ended) IT (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2012-001419-21 Sponsor Protocol Number: TPVAHC2012 Start Date*: 2013-08-15
    Sponsor Name:Universitätsklinikum Bonn
    Full Title: An open label, randomised, non-inferiority trial of pegylated interferon, ribavirin and telaprevir versus pegylated interferon and ribavirin alone in the response guided treatment of acute hepatiti...
    Medical condition: Acute Hepatitis C in HIV co-infection
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2011-001463-51 Sponsor Protocol Number: NESS-STUDY Start Date*: 2011-07-14
    Sponsor Name:Servicio de Enfermedades Infecciosas. Unidad VIH. Hospital Universitari de Bellvitge
    Full Title: EVALUACIÓN DE LOS NIVELES DE ETRAVIRINA EN PLASMA SEMINAL EN SUJETOS INFECTADOS POR EL VIH
    Medical condition: HIV
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10008922 Chronic infection with HIV LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-007086-21 Sponsor Protocol Number: TMC125-TiDP35-C213 Start Date*: 2009-01-23
    Sponsor Name:Tibotec Pharmaceuticals
    Full Title: A Phase II, open-label trial to evaluate the safety, tolerability and antiviral activity of TMC125 in antiretroviral experienced HIV-1 infected children and adolescents.
    Medical condition: HIV-1 infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020192 HIV-1 LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) BE (Completed) PT (Completed) ES (Completed) FR (Completed) NL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-002413-22 Sponsor Protocol Number: Be-OnE1/08-03-2016 Start Date*: 2016-10-31
    Sponsor Name:OSPEDALE SAN RAFFAELE
    Full Title: Open label, Randomized (1:1), clinical trial to evaluate switching from dual regimens based on Dolutegravir plus a reverse transcriptase inhibitor to elvitegravir/cobicistat/emtricitabine/tenofovi...
    Medical condition: HIV infection
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10008922 Chronic infection with HIV LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 17 03:06:33 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA